Erratum: Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689)

Holbrook E. Kohrt; A. Dimitrios Colevas; Roch Houot; Kipp Weiskopf; Matthew J. Goldstein; Peder Lund; Antonia Mueller; Idit Sagiv-Barfi; Aurelien Marabelle; Ruth Lira; Emily Troutner; Lori Richards; Amanda Rajapaska; Jonathan Hebb; Cariad Chester; Erin Waller; Anton Ostashko; Wen Kai Weng; Lieping Chen; Debra Czerwinski; Yang Xin Fu; John Sunwoo; Ronald Levy

doi:10.1172/JCI73014

Erratum: Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689)

Holbrook E. Kohrt, A. Dimitrios Colevas, Roch Houot, Kipp Weiskopf, Matthew J. Goldstein, Peder Lund, Antonia Mueller, Idit Sagiv-Barfi, Aurelien Marabelle, Ruth Lira, Emily Troutner, Lori Richards, Amanda Rajapaska, Jonathan Hebb, Cariad Chester, Erin Waller, Anton Ostashko, Wen Kai Weng, Lieping Chen, Debra CzerwinskiYang Xin Fu, John Sunwoo, Ronald Levy

Research output: Contribution to journal › Comment/debate

5 Citations (Scopus)

Abstract

Stanford University School of Medicine recently notified the JCI of concerns regarding Figure 4, B, C, and E, Figure 5, B, D, and F, and Figure 6B and indicated that the original source data for these figures could not be located. In accordance with the institutional recommendation, the JCI is retracting this article.

Original language	English
Pages (from-to)	2595
Number of pages	1
Journal	Journal of Clinical Investigation
Volume	129
Issue number	6
DOIs	https://doi.org/10.1172/JCI73014
Publication status	Published - 3 Jun 2019

Access to Document

10.1172/JCI73014

Cite this

Kohrt, H. E., Colevas, A. D., Houot, R., Weiskopf, K., Goldstein, M. J., Lund, P., Mueller, A., Sagiv-Barfi, I., Marabelle, A., Lira, R., Troutner, E., Richards, L., Rajapaska, A., Hebb, J., Chester, C., Waller, E., Ostashko, A., Weng, W. K., Chen, L., ... Levy, R. (2019). Erratum: Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689). Journal of Clinical Investigation, 129(6), 2595. https://doi.org/10.1172/JCI73014

@article{7650187122b34166bee56d6c1a0d7e55,

title = "Erratum: Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689)",

abstract = "Stanford University School of Medicine recently notified the JCI of concerns regarding Figure 4, B, C, and E, Figure 5, B, D, and F, and Figure 6B and indicated that the original source data for these figures could not be located. In accordance with the institutional recommendation, the JCI is retracting this article.",

author = "Kohrt, {Holbrook E.} and Colevas, {A. Dimitrios} and Roch Houot and Kipp Weiskopf and Goldstein, {Matthew J.} and Peder Lund and Antonia Mueller and Idit Sagiv-Barfi and Aurelien Marabelle and Ruth Lira and Emily Troutner and Lori Richards and Amanda Rajapaska and Jonathan Hebb and Cariad Chester and Erin Waller and Anton Ostashko and Weng, {Wen Kai} and Lieping Chen and Debra Czerwinski and Fu, {Yang Xin} and John Sunwoo and Ronald Levy",

year = "2019",

month = jun,

day = "3",

doi = "10.1172/JCI73014",

language = "English",

volume = "129",

pages = "2595",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

number = "6",

}

Kohrt, HE, Colevas, AD, Houot, R, Weiskopf, K, Goldstein, MJ, Lund, P, Mueller, A, Sagiv-Barfi, I, Marabelle, A, Lira, R, Troutner, E, Richards, L, Rajapaska, A, Hebb, J, Chester, C, Waller, E, Ostashko, A, Weng, WK, Chen, L, Czerwinski, D, Fu, YX, Sunwoo, J & Levy, R 2019, 'Erratum: Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689)', Journal of Clinical Investigation, vol. 129, no. 6, pp. 2595. https://doi.org/10.1172/JCI73014

TY - JOUR

T1 - Erratum

T2 - Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689)

AU - Kohrt, Holbrook E.

AU - Colevas, A. Dimitrios

AU - Houot, Roch

AU - Weiskopf, Kipp

AU - Goldstein, Matthew J.

AU - Lund, Peder

AU - Mueller, Antonia

AU - Sagiv-Barfi, Idit

AU - Marabelle, Aurelien

AU - Lira, Ruth

AU - Troutner, Emily

AU - Richards, Lori

AU - Rajapaska, Amanda

AU - Hebb, Jonathan

AU - Chester, Cariad

AU - Waller, Erin

AU - Ostashko, Anton

AU - Weng, Wen Kai

AU - Chen, Lieping

AU - Czerwinski, Debra

AU - Fu, Yang Xin

AU - Sunwoo, John

AU - Levy, Ronald

PY - 2019/6/3

Y1 - 2019/6/3

N2 - Stanford University School of Medicine recently notified the JCI of concerns regarding Figure 4, B, C, and E, Figure 5, B, D, and F, and Figure 6B and indicated that the original source data for these figures could not be located. In accordance with the institutional recommendation, the JCI is retracting this article.

AB - Stanford University School of Medicine recently notified the JCI of concerns regarding Figure 4, B, C, and E, Figure 5, B, D, and F, and Figure 6B and indicated that the original source data for these figures could not be located. In accordance with the institutional recommendation, the JCI is retracting this article.

UR - http://www.scopus.com/inward/record.url?scp=85066607597&partnerID=8YFLogxK

U2 - 10.1172/JCI73014

DO - 10.1172/JCI73014

M3 - Comment/debate

C2 - 24837434

AN - SCOPUS:85066607597

SN - 0021-9738

VL - 129

SP - 2595

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 6

ER -

Erratum: Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689)

Abstract

Access to Document

Other files and links

Cite this